000 -LEADER |
fixed length control field |
04050nam a22004335i 4500 |
001 - CONTROL NUMBER |
control field |
978-1-59745-272-4 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
DE-He213 |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20161121230737.0 |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
fixed length control field |
cr nn 008mamaa |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
100301s2007 xxu| s |||| 0|eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9781597452724 |
-- |
978-1-59745-272-4 |
024 7# - OTHER STANDARD IDENTIFIER |
Standard number or code |
10.1007/978-1-59745-272-4 |
Source of number or code |
doi |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
RC681-688.2 |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MJD |
Source |
bicssc |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MED010000 |
Source |
bisacsh |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
616.12 |
Edition number |
23 |
245 10 - TITLE STATEMENT |
Title |
Stem Cells And Myocardial Regeneration |
Medium |
[electronic resource] / |
Statement of responsibility, etc. |
edited by Marc S. Penn. |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Place of production, publication, distribution, manufacture |
Totowa, NJ : |
Name of producer, publisher, distributor, manufacturer |
Humana Press, |
Date of production, publication, distribution, manufacture, or copyright notice |
2007. |
300 ## - PHYSICAL DESCRIPTION |
Other physical details |
online resource. |
336 ## - CONTENT TYPE |
Content type term |
text |
Content type code |
txt |
Source |
rdacontent |
337 ## - MEDIA TYPE |
Media type term |
computer |
Media type code |
c |
Source |
rdamedia |
338 ## - CARRIER TYPE |
Carrier type term |
online resource |
Carrier type code |
cr |
Source |
rdacarrier |
347 ## - DIGITAL FILE CHARACTERISTICS |
File type |
text file |
Encoding format |
PDF |
Source |
rda |
490 1# - SERIES STATEMENT |
Series statement |
Contemporary Cardiology |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Economic impact of heart failure -- The Challenge for Stem Cell Therapy -- Cells Of Interest For Myocardial Regeneration -- Hematopoietic Stem Cells for Myocardial Regeneration -- Mesenchymal Stem Cells for Cardiac Therapy -- Multipotent Adult Progenitor Cells -- Mesenchymal Progenitor Cells for Vascular Network Formation and Cardiac Muscle Regeneration -- Umbilical Cord Blood Stem Cells for Myocardial Regeneration and Angiogenesis -- Endogenous Cardiac Stem Cells -- Embryonic Stem Cells for Myocardial Repair -- Mechanisms And Critical Pathways Involved In Myocardial Repair -- Chemokine and Homing Factor Expression in Acute Myocardial Infarction and Chronic Heart Failure -- Stem Cell Differentiation Toward a Cardiac Myocyte Phenotype -- Electrical Coupling and/or Ventricular Tachycardia Risk of Cell Therapy -- Cell Therapy for Myocardial Damage -- Strategies For Cell Delivery: Advantages/Disadvantages -- Aspects of Percutaneous Cellular Cardiomyoplasty -- Stem Cells and Myocardial Regeneration -- Stem Cell-Based Clinical Trials For Cardiac Dysfunction -- Measures of Effective Cell-Based Therapy -- Whole Bone Marrow Transplantation -- Clinical Angioblast Therapy -- Use of Skeletal Myoblasts for the Treatment of Chronic Heart Failure -- Bone Marrow and Angioblast Transplantation -- Strategies for Cytokine Modification and Stem Cell Mobilization for Acute Myocardial Infarction -- Summary/Future Challenges -- Summary and Future Challenges. |
520 ## - SUMMARY, ETC. |
Summary, etc. |
Over the past 5 years there has been great excitement and controversy in the scientific, financial, and lay literature for the potential of stem cell-based strategies for the prev- tion and treatment of chronic heart failure (CHF). Not that long ago we believed we were born with a set number of cardiac myocytes and that once damaged there was no hope to replace them. The interest in the field stems from the magnitude of cardiovascular disease in the world. Our ability to treat and help patients survive acute myocardial infarction (MI) has resulted in a near epidemic of CHF. There are more than 5 million Americans who currently carry the diagnosis of CHF. With more than 1 million MIs a year in the United States, there are approx 500,000 new cases of CHF diagnosed each year. The goal of Stem Cells and Myocardial Regeneration is to present, in a coherent manner, the current state of knowledge of stem cell-based therapies for cardiac dysfunction, including current findings in both the laboratory and the clinic trials. The first section of this Stem Cells and Myocardial Regeneration focuses on the magnitude of the problem and the successes and failures of what we consider optimal medical therapy. It is on this background that stem cell-based therapy needs to build. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Medicine. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Cardiology. |
650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Medicine & Public Health. |
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Cardiology. |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Penn, Marc S. |
Relator term |
editor. |
710 2# - ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
SpringerLink (Online service) |
773 0# - HOST ITEM ENTRY |
Title |
Springer eBooks |
776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
Relationship information |
Printed edition: |
International Standard Book Number |
9781588296641 |
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
Uniform title |
Contemporary Cardiology |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Uniform Resource Identifier |
http://dx.doi.org/10.1007/978-1-59745-272-4 |
912 ## - |
-- |
ZDB-2-SME |